Press ESC to close

    Blog

    See below to check out the latest articles

      • Buzz
        Buzz
      • 11 October 2024

      Epic Cannabis Fails You Should Know About: MedMen, Eaze And Others Go Down In California Meltdowns

      MedMen was once celebrated as the 'Apple Store of Weed and reached a $2 billion valuation. By April...

      • Buzz
        Buzz
      • 11 October 2024

      ThrivePOP Takes the Stage at MJBizCon:

      Explore the Marketing Impact of AI on Consumer Experiences!

      • Buzz
        Buzz
      • 10 October 2024

      Canapa Expands Portfolio with Comac Beverage Processing and Filling Solutions

      Canapa by Paxiom is excited to announce the addition of Comac Beverage processing and filling...

      • Buzz
        Buzz
      • 9 October 2024

      Elon Musk's X Is 'Safe Space' To Say Weed: 'The Only Social Platform Where You Can Talk About Cannabis Openly'

      The head of cannabis at X shares the vision of the platform and the opportunity for cannabis...

      • Buzz
        Buzz
      • 8 October 2024

      Crafting A 'Mixed Martial Arts' Plant: Texas Scientists Develop Drought-Resistant Hemp Strain

      Texas A&M's hemp breeding program has developed a drought-resistant hemp strain suited for extreme...

      • Buzz
        Buzz
      • 7 October 2024

      Budtenders Letting You Down? Meet The Weed Bot That Actually Knows What You Want

      AI uses customers' purchase histories and other data points to recommend strains based on...

      • Buzz
        Buzz
      • 4 October 2024

      Post-Harvest Optimization Technology Consistently Produces Premium-Quality Cannabis, Studies Show

      Cannatrol’s technology improves terpene retention by 16%, preserving cannabis flavor and potency.

      ...

      • Buzz
        Buzz
      • 4 October 2024

      Canada: Bubble Bud calls on government to address flaws in cannabis beverage testing

      Bubble Bud is calling for Health Canada to take immediate action to address critical flaws in...

      • Buzz
        Buzz
      • 3 October 2024

      Review of Studies on Cannabis for Neuropathic Pain

      Researchers analyzed studies from the past two decades on the impact of cannabinoids on neuropathic...

      • Buzz
        Buzz
      • 1 October 2024

      Pharma Company Gets FDA Green Light For Next Phase Trial For Tourette Syndrome

      SciSparc receives FDA approval for a Phase IIb trial of a cannabinoid based treatment for Tourette...

      Subscribe Here!

      Drive people to your products and services

      Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.